Mean change in body weight from baseline: Cl=confidence interval
[29, 30, 31] Risk factors: Diabetes (especially in combination with SGLT2 inhibitors use) Reduced oral intake and severe GI symptoms Dehydration Presentation: Nausea, vomiting, abdominal pain Anion gap metabolic acidosis Elevated ketones Normal or mildly elevated glucose Key point: EDKA has not been observed in non-diabetic patients in large cohort data
afterwards, DR tends to improve as the body establishes a new homeostasis
Gastroparesis, one of the primary side effects cited, can lead to chronic nausea, vomiting, and malnutrition, significantly affecting quality of life
Combination formulations may also have different pH optima for each component, forcing a compromise pH that may not be ideal for either peptide individually
But it certainly wasnt causing depression